arGEN-X advances a third therapeutic antibody program into preclinical development: http://t.co/hBB8aUOQ
posted 16 hours ago
FlandersBio’s team is there to help its members and the Flemish life sciences and biotech sector. Please contact us for any questions you may have about FlandersBio membership, FlandersBio benefits or any specific questions about the life sciences sector.





